FDA inspection
Pfizer Asia Manufacturing Pte Ltd.: FDA inspection ending Oct 27, 2021
FDA inspection 1156359 · Voluntary Action Indicated (VAI) · Singapore
Key facts
| Inspection ID | 1156359 |
|---|---|
| Firm | Pfizer Asia Manufacturing Pte Ltd. |
| FEI number | 3003901862 |
| Address | 31 Tuas South Avenue 6 |
| City | Singapore |
| Country | Singapore |
| Fiscal year | 2022 |
| Inspection end date | Oct 27, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data